Latest news with #DavideMassa
Yahoo
24-05-2025
- Sport
- Yahoo
Why A Penalty Vs Lazio But Not Now? – Massa Under Fire For Penalty Decision In Como 0-2 Inter Milan Serie A Clash
Why A Penalty Vs Lazio But Not Now? – Massa Under Fire For Penalty Decision In Como 0-2 Inter Milan Serie A Clash Davide Massa has received criticism for his decision not to award Como a penalty against Inter Milan in yesterday's Serie A clash. Today's print edition of Rome-based newspaper Corriere dello Sport, via FCInterNews, question why Federico Dimarco's handball didn't warrant a penalty if that of Yann Bisseck the previous week did. Advertisement Como wanted a penalty early in the second half of yesterday's Serie A clash at the San Siro. The Lariani may have been down a man. However, they were pushing for a response right after halftime, playing the ball around Inter's penalty area. A shot from Nico Paz made contact with the arm of Inter wingback Federico Dimarco. Therefore, the Como players appealed to referee Davide Massa for a spot kick. However, the referee waved these appeals away. He evidently felt that there had not been a deliberate handball by Dimarco. Davide Massa Under Fire For Penalty Decision In Como Vs Inter Milan Clash FLORENCE, ITALY – OCTOBER 08: Federico Dimarco of Italy in action during a Italy training session at Centro Tecnico Federale di Coverciano on October 08, 2024 in Florence, Italy. (Photo by) In the view of the Corriere, however, Dimarco's handball was punishable. Advertisement The Italian international's arm was away from his body. And if anything he was moving his arm out, making his body larger. This was exactly the offense for which Lazio received a penalty in the dramatic finale of their match against Inter last weekend. Therefore, the Corriere question why it was a penalty then – but not yesterday.
Medscape
19-05-2025
- Health
- Medscape
New High-Risk TNBC Subgroup Identified
New data support integrating tumor-infiltrating lymphocyte levels with nodal status to improve risk stratification in women with triple-negative breast cancer (TNBC) and pathological complete response (pCR) following neoadjuvant treatment. Specifically, patients with lower levels of tumor-infiltrating lymphocytes had a higher risk for relapse and worse overall survival than those with higher levels, said Davide Massa, MD, medical oncologist, University of Padua, Padua, Italy. 'For every 5% increase in [tumor-infiltrating lymphocytes], we saw a 10% reduction in the risk of distant relapse-free survival and an 11% reduction in the risk of death,' he reported in an oral presentation at the ESMO Breast Cancer 2025 meeting. And when combining tumor-infiltrating lymphocytes and nodal status, 'we could identify a previously unrecognized high-risk subgroup — patients with low tumor-infiltrating lymphocytes and positive nodal involvement,' Massa noted. These data may help guide post-neoadjuvant strategies for patients otherwise considered to have favorable long-term outcomes, he added. Refining Risk Stratification In TNBC, pCR after neoadjuvant treatment is associated with favorable outcomes, but a subset of patients remains at risk for relapse. Massa and his colleagues wanted to find out if they could identify these patients. Stromal tumor-infiltrating lymphocytes in TNBC are a strong independent prognostic biomarker associated with improved outcomes, yet their role in risk stratification within the pCR subgroup has been underexplored. The retrospective study included 1532 patients with stage I-III TNBC who received neoadjuvant therapy between 2000 and 2023 at 12 European centers. Of these patients, 733 (48%) had a pCR. Tumor-infiltrating lymphocyte levels, assessed in treatment-naive biopsies, were available for 613 patients with a pCR (84%), which comprised the study cohort. The median follow-up was 4.2 years. In multivariate analyses, both tumor-infiltrating lymphocytes and nodal status were independent prognostic factors for distant relapse-free survival and overall survival in patients with a pCR. Patients with positive nodal status had significantly worse distant relapse-free survival (adjusted hazard ratio [aHR], 2.38) and overall survival (aHR, 3.45) compared with those with negative nodal status. When evaluating tumor-infiltrating lymphocytes at a predefined cutoff of 30%, patients with higher tumor-infiltrating lymphocyte levels demonstrated better survival outcomes. Patients with tumor-infiltrating lymphocyte levels ≥ 30% had a 5-year distant relapse-free survival elapsed survival rate of 96.3% compared with 89.5% in patients with levels < 30% (aHR, 0.42). Similarly, in patients with higher tumor-infiltrating lymphocyte levels, 5-year overall survival was 98.1% compared with 91.5% in those with lower levels (aHR, 0.33). When combining tumor-infiltrating lymphocyte and nodal status information, patients with low tumor-infiltrating lymphocyte levels and positive nodal involvement had significantly worse 5-year distant relapse-free survival compared with all other subgroups (82.6% vs at least 94.7%; aHR, 3.17). This finding held for 5-year overall survival (84.3% vs at least 97%; aHR, 5.09). Sensitivity analyses confirmed the study findings for both distant relapse-free survival and overall survival. 'This is a simple, cost-effective, and universally applicable stratification tool that relies only on hematoxylin and eosin-stained slides and no proprietary technology, which can be implemented in treatment-tailoring trials,' Massa said. Massa noted that a prospective study to validate these findings is ongoing. Kevin Kalinsky, MD, with Winship Cancer Institute, Emory University, Atlanta, who served as study discussant, called the results 'intriguing' and 'hypothesis-generating.' Kalinsky said it will be important to validate whether low tumor-infiltrating lymphocytes are associated with worse outcomes regardless of pCR. And, if so, what is the role of antibody-drug conjugates with or without immunotherapy — a question that may be answered in the ongoing OptimICE-pCR trial, he added. Another question is whether patients with stage I TNBC and high tumor-infiltrating lymphocytes can opt out of systemic therapy, as is being explored in the OPTImaL and ETNA trials. Finally, Kalinsky said it will be worth exploring the use of tumor-infiltrating lymphocytes and other markers to tailor the selection of chemotherapy in TNBC, something the NeoTRACT trial is investigating.
Yahoo
17-03-2025
- Sport
- Yahoo
Ex Serie A Referee Questions Argentina Megastar's Disallowed Goal In Atalanta 0-2 Inter Milan Win: 'Doubt Remains'
Former Serie A referee Gianpaolo Calvarese took stock of Davide Massa's decision to disallow Lautaro Martinez's goal against Atalanta. According to Tuttosport via TMW, Calvarese refused to agree with Massa's call, admitting it's 'debatable.' Simone Inzaghi's team pulled off a crucial 2-0 victory at the Gewiss Stadium last night. Indeed, Carlos Augusto and El Toro scored in the second half to seal Inter's eighth straight win against La Dea. However, after a relatively quiet first half, the game gained intensity in the second half, especially after Inter's goal. The first incident took place in the 72nd minute. Lautaro thought he had doubled Inter's lead, only for Massa to overturn his goal for a foul in the build-up. After that, the experienced Serie A referee showed three red cards. Ederson and Gian Piero Gasperini received their marching orders as Atalanta's frustration boiled over at 0-1. Meanwhile, Alessandro Bastoni picked up a needless second booking a few minutes from the final whistle. 'After officiating the Champions League first-leg game between PSG and Liverpool at the Parc des Princes, Davide Massa returned to referee a big match in Serie A,' the analysis read. 'At the Gewiss Stadium, he managed the overall tension well with his experience. 'The main incidents occurred in the second half, interrupted for more than six minutes to allow medical assistance for a fan. 'He disallowed Lautaro's goal at 0-1 due to a prior shoulder charge by Lautaro on Djimsiti. However, he made no attempt to play the ball. 'The foul is debatable, but it falls within the referee's discretion. 'Then came the three red cards. 'First, Ederson, who openly protested against the referee and sarcastically applauded him, earning two yellow cards in seconds. 'Then Gasperini, who protested from the bench. 'And finally Bastoni, who, already booked and having taken a risk earlier, took down Maldini.'
Yahoo
17-03-2025
- Sport
- Yahoo
Serie A Referee ‘Inconsistent' In Atalanta 0-2 Inter Milan Serie A Clash
Davide Massa failed to live up to the billing in last night's Serie A match between Atalanta and Inter Milan at the Gewiss Stadium. According to Gazzetta dello Sport via FCInterNews, Massa's decision were not consistent. Simone Inzaghi oversaw another emphatic win against La Dea. Indeed, Carlos Augusto and Lautaro Martinez scored in a pivotal 2-0 victory in Bergamo. Therefore, the defending Serie A champions have beaten Atalanta in all three meetings this season. Furthermore, each win saw them score multiple unanswered goals. In fact, Inzaghi's charges accumulated an eye-catching 8-0 aggregate scoreline across those triumphs. The game was plain sailing for Massa in the opening half an hour. However, he made his life complicated in the 72nd minute by overturning Lautaro's goal for a foul in the build-up. Then, he sent off Atalanta midfielder Ederson in the 81st minute, showing him two yellows in quick succession. In all fairness, Massa didn't have another choice as the Brazilian blacked out for 60 seconds. Meanwhile, he could've avoided giving Alessandro Bastoni his marching orders in second-half stoppage time. The foul on Daniel Maldini was soft and didn't require a second booking.
Al-Ahram Weekly
05-03-2025
- Sport
- Al-Ahram Weekly
Live score: PSG v Liverpool (UEFA Champions League) - Talents Abroad
Ahram Online is providing a live score coverage for Wednesday's match between PSG and Liverpool in the 1st leg of the UEFA Champions League Round of 16 PSG v Liverpool Stay tuned as match is due to start at 22:00 Cairo time (GMT+2) Venue: Parc des Princes (Paris) Referee: Davide Massa (For more sports news and updates, follow Ahram Online Sports on Twitter at @AO_Sports and on Facebook at AhramOnlineSports.) Follow us on: Facebook Instagram Whatsapp Short link:
